发明授权
US08143408B2 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
失效
用于治疗疼痛的N-（8-杂芳基四氢萘-2-基）或N-（5-杂芳基苯并二氢吡喃-3-基）甲酰胺衍生物
- 专利标题： N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
- 专利标题（中）： 用于治疗疼痛的N-（8-杂芳基四氢萘-2-基）或N-（5-杂芳基苯并二氢吡喃-3-基）甲酰胺衍生物
-
申请号： US12596878申请日： 2008-04-22
-
公开(公告)号： US08143408B2公开(公告)日： 2012-03-27
- 发明人: Yevgeni Besidski , Inger Kers , Martin Nylöf , Lars Sandberg , Karin Skogholm
- 申请人： Yevgeni Besidski , Inger Kers , Martin Nylöf , Lars Sandberg , Karin Skogholm
- 申请人地址： SE Sodertalje
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： SE Sodertalje
- 代理商 Kenneth F. Mitchell
- 国际申请： PCT/SE2008/050459 WO 20080422
- 国际公布： WO2008/130320 WO 20081030
- 主分类号： C07D401/00
- IPC分类号： C07D401/00
摘要：
The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.
公开/授权文献
信息查询
